Adjuvanted recombinant candidates to prime / boost covid-19 RNA vaccines
Ended Project Grant Awarded Last action
- Award ID
- R43IP001164
- Recipient
-
PAI Life Sciences Inc. UEI MSMLUCM9DRT6
- Awarding agency
-
Office of Financial Resources
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $243,000
Award facts
- Assistance listing
- 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance
- Completion date
- Originally
- Funding agency
- Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
- Place of performance
- Wisconsin, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $243,000 |
Quick answers
Who received award R43IP001164?
R43IP001164 was awarded to PAI Life Sciences Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2021.
How much is award R43IP001164 worth?
$243,000 has been obligated on R43IP001164.
Which agency awarded R43IP001164?
Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43IP001164, with funding from Office of the Director (Centers for Disease Control and Prevention).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award